{
    "root": "6ff4192b-057c-4100-9cc6-4227577fb146",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Hydrocortisone",
    "value": "20240312",
    "ingredients": [
        {
            "name": "HYDROCORTISONE",
            "code": "WI4X0X7BPJ"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        }
    ],
    "indications": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.",
    "contraindications": "Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions": "Hydrocortisone Cream USP, 2.5%\n                  \n                  NDC: 72162-1382-2: 28 g in a TUBE\n                  NDC: 72162-1382-4: 20 g in a TUBE\n                  Repackaged/Relabeled by:\n                  Bryant Ranch Prepack, Inc.\n                  Burbank, CA 91504",
    "adverseReactions": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation."
}